Comprehensive treatment for breast cancer has evaded health specialists for decades. What could be the reason for this situation? What has not been done in spite of billions of dollars used in research and treatment? Fortunately, Tempus, a cancer-fighting startup from Groupon founder Erick Lefkofsky has discovered the gap and come up with a solution.Tempus has observed that despite the rising number of deaths from breast cancer, its data collection, storage and use has remained minimal. Effective treatment of breast cancer calls for past records on how it starts, the interventions carried out and its prognosis.
Cancer is an abnormal growth and proliferation of cells. For effective treatment, it is important to study the molecular cell abnormalities and genetic mutation that make cancer cells unresponsive to chemotherapy. This study phase has been conducted by many research centers and hospitals. Unfortunately, the studies and research data have remained in individual research centers and hospitals.Tempus has come out to remedy this situation. The organization plans to break this individual approach in breast cancer treatment by introducing an operating system for cancer patients. Tempus, in partnership with the University of Chicago Medicine, will analyze the data in this platform from the over 1,000 breast cancer patients. The data collected and analyzed will assist doctors and researchers in uncovering the patterns that can predict how patients will respond to treatment.
Cancer treatment presents a challenge as it requires targeted therapy of the cancerous cells. Besides, the constant mutations and individual genetic makeup further complicate the treatment regimen. To overcome this hindrance, Tempus uses machines learning and genomic sequencing to help physicians in making real-time personalized treatment judgments.To help in realizing this patient focused treatment dubbed Precision Promise trial, Tempus has been selected by Pancreatic Cancer Action Network (PANCan) to utilize its technology in supporting this revolutionary effort.Erick Lefkofsky is the co-founder and CEO of Tempus, the technological company that has built an operating system to battle cancer. He has a degree from the University of Michigan and a Juris Doctor from University of Michigan Law School. He is the author of Accelerated Disruption and is currently an adjunct professor at the University of Chicago.Lefkofsky is the co-founder of Lightbank and Uptake Technologies. Together with his wife, Liz, they have established Lefkofsky Family Foundation to assist disadvantaged communities.